Technology Licensing Opportunities

The UILO has over 400 active license and assignment agreements to its technologies.

Search current technology licensing opportunities

Additional UBC technologies are also available for licensing, usually under fixed, pre-established terms on Flintbox

See featured technologies

T Cell Receptor Zeta Chain Antibody

The invention is a novel monoclonal antibody specific for the T cell receptor zeta chain and is referred to as G3.

Read More

Antibodies against Synaptic Proteins

Monoclonal Antibodies that are Reactive against a Range of Synaptic Proteins

Read More


Automatic high-quality hexahedral mesh generation  

Read More

3D Microscope Stabilization System

Real-time drift-free super-resolution imaging at variable depth

Read More

Androgen Receptor Inhibitors

The development of anti-androgens with a new mechanism of action for treatment of castration resistant prostate cancer

Read More

Self-propelled Particles for Hemostatic Applications

Improved coagulation of blood in hemorrhage   

Read More

Small molecules that alter SRSF10-Mediated Alternative Splicing

Novel small molecules with demonstrated activity that (i) inhibit replication of drug-resistant strains of HIV; (ii) promote exon 7 inclusion in SMN2 in a patient-derived cell line and; (iii) reduce the transcription of BCLAF1 transcript variant in colon cancer cell lines

Read More

Therapeutics for Age-Related Macular Degeneration

Polyphosphate (polyP) for the treatment of complement-associated disorders

Read More